Related references
Note: Only part of the references are listed.Positron Emission Tomography Imaging Demonstrates Correlation between Behavioral Recovery and Correction of Dopamine Neurotransmission after Gene Therapy
Ludovic Leriche et al.
JOURNAL OF NEUROSCIENCE (2009)
Gene Therapy Continues to Mature and to Face Challenges
David A. Williams
MOLECULAR THERAPY (2009)
Arvid Carlsson: An Early Pioneer in Translational Medicine
Julie K. Andersen
SCIENCE TRANSLATIONAL MEDICINE (2009)
Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice
Linan Chen et al.
JOURNAL OF NEUROSCIENCE (2008)
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
J. L. Eberling et al.
NEUROLOGY (2008)
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in Parkinsonian rats
Manolo Carta et al.
BRAIN (2007)
Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC
Krystof S. Bankiewicz et al.
MOLECULAR THERAPY (2006)
A dose-ranging study of AAV-hAADC therapy in parkinsonian monkeys
John R. Forsayeth et al.
MOLECULAR THERAPY (2006)
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications
C. Warren Olanow et al.
LANCET NEUROLOGY (2006)
Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys
KS Bankiewicz et al.
EXPERIMENTAL NEUROLOGY (2006)
Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors
T Carlsson et al.
BRAIN (2005)
Optimizing levodopa phannacokinetics:: Intestinal infusion versus oral sustained-release tablets
D Nyholm et al.
CLINICAL NEUROPHARMACOLOGY (2003)
Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer
D Kirik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes
SI Muramatsu et al.
HUMAN GENE THERAPY (2002)
Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease
Y Shen et al.
HUMAN GENE THERAPY (2000)
Share Paper
